Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: a comprehensive review
Breast cancer (BC) is the most common cancer in women and poses a serious threat to their
health. Despite familiarity with factors affecting its etiology, initiation, progression, treatment …
health. Despite familiarity with factors affecting its etiology, initiation, progression, treatment …
microRNAs orchestrate pathophysiology of breast cancer brain metastasis: advances in therapy
Brain metastasis (BM) predominantly occurs in triple-negative (TN) and epidermal growth
factor 2 (HER2)-positive breast cancer (BC) patients, and currently, there is an unmet need …
factor 2 (HER2)-positive breast cancer (BC) patients, and currently, there is an unmet need …
Gene expression and miRNAs profiling: function and regulation in human epidermal growth factor receptor 2 (HER2)-positive breast cancer
RM Sareyeldin, I Gupta, I Al-Hashimi, HA Al-Thawadi… - Cancers, 2019 - mdpi.com
Breast cancer is the second most common cause of cancer-related deaths among women
worldwide. It is a heterogeneous disease with four major molecular subtypes. One of the …
worldwide. It is a heterogeneous disease with four major molecular subtypes. One of the …
miR-770-5p regulates EMT and invasion in TNBC cells by targeting DNMT3A
MicroRNAs (miRNAs) are shown to regulate various processes in cancer like motility and
invasion that are key features of the metastatic triple negative breast cancer (TNBCs) …
invasion that are key features of the metastatic triple negative breast cancer (TNBCs) …
[HTML][HTML] New insights of miRNA molecular mechanisms in breast cancer brain metastasis and therapeutic targets
Brain metastases in breast cancer (BC) patients are often associated with a poor prognosis.
Recent studies have uncovered the critical roles of miRNAs in the initiation and progression …
Recent studies have uncovered the critical roles of miRNAs in the initiation and progression …
[HTML][HTML] Circular RNA circ_ASAP2 promotes cell viability, migration, and invasion of gastric cancer cells by regulating the miR-770-5p/CDK6 axis
B Chen, F Ji, X Wen, Z Jin - International journal of clinical and …, 2020 - ncbi.nlm.nih.gov
Background: Gastric cancer (GC) is one of the most common causes of cancer death.
GSE83521 microarray analysis suggested that circular RNA circ_ASAP2 …
GSE83521 microarray analysis suggested that circular RNA circ_ASAP2 …
[HTML][HTML] Crosstalk between breast cancer-derived microRNAs and brain microenvironmental cells in breast cancer brain metastasis
MS Khan, GL Wong, C Zhuang, MK Najjar… - Frontiers in …, 2024 - pmc.ncbi.nlm.nih.gov
Breast cancer is the most frequent malignancy in women, constituting 15.2% of all new
cancers diagnosed in the United States. Distant breast cancer metastasis accounts for the …
cancers diagnosed in the United States. Distant breast cancer metastasis accounts for the …
[HTML][HTML] miRNAs as biomarkers of therapeutic response to HER2-targeted treatment in breast cancer: a systematic review
TH Vo, EL Esam, E Jordan, O O'Donovan… - … and Biophysics Reports, 2024 - Elsevier
Breast cancer is the most common type of lethal cancer in women globally. Women have a 1
in 8 chance of developing breast cancer in their lifetime. Among the four primary molecular …
in 8 chance of developing breast cancer in their lifetime. Among the four primary molecular …
MicroRNA: Promising roles in cancer therapy
A Hashemi, G Gorji-Bahri - Current Pharmaceutical …, 2020 - ingentaconnect.com
MicroRNAs (miRNA) are small non-coding RNAs that act as one of the main regulators of
gene expression. They are involved in maintaining a proper balance of diverse processes …
gene expression. They are involved in maintaining a proper balance of diverse processes …
Biologicals to direct nanotherapeutics towards HER2-positive breast cancers
HER2-positive breast cancer, an aggressive cancer, is treated with combinations of
conventional anticancer drugs viz., cytotoxic drugs, nibs, and mAbs. Major limitations …
conventional anticancer drugs viz., cytotoxic drugs, nibs, and mAbs. Major limitations …